Search Results
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Search for other papers by Stan R Ursem in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
Amsterdam Public Health, Amsterdam, The Netherlands
Search for other papers by Wendy P J den Elzen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development, Amsterdam, The Netherlands
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Introduction Thyroid disorders are common. When a thyroid disorder is suspected, the standard procedure is measuring the serum or plasma thyroid-stimulating hormone (TSH). Accurate TSH measurements are important for timely diagnosis since
Search for other papers by James Magner in
Google Scholar
PubMed
Introduction Who discovered insulin? Penicillin? These questions have answers although they involve caveats and stories rather than one-word responses. So, who discovered thyroid-stimulating hormone (TSH)? In fact, the answer includes many
Search for other papers by Mahdi Kamoun in
Google Scholar
PubMed
Search for other papers by Michèle d'Herbomez in
Google Scholar
PubMed
Search for other papers by Christine Lemaire in
Google Scholar
PubMed
Search for other papers by Armelle Fayard in
Google Scholar
PubMed
Search for other papers by Rachel Desailloud in
Google Scholar
PubMed
Search for other papers by Damien Huglo in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
Introduction Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare tumor and represents less than 2% of all pituitary tumors [ 1 , 2 , 3 ]. The coexistence of autoimmune thyroid disease and TSHoma
Search for other papers by Enrique Soto-Pedre in
Google Scholar
PubMed
Search for other papers by Moneeza K. Siddiqui in
Google Scholar
PubMed
Search for other papers by Ify Mordi in
Google Scholar
PubMed
Search for other papers by Cyrielle Maroteau in
Google Scholar
PubMed
Search for other papers by Jimena Soto-Hernaez in
Google Scholar
PubMed
Search for other papers by Colin N.A. Palmer in
Google Scholar
PubMed
Search for other papers by Ewan R. Pearson in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom
Search for other papers by Graham P. Leese in
Google Scholar
PubMed
Introduction Genome-wide association studies (GWASs) have found association signals with serum thyroid-stimulating hormone (TSH) concentrations and/or hypothyroidism [ 1 - 4 ]. Replication studies in independent samples are scarce but
Search for other papers by Muhammed Erkam Sencar in
Google Scholar
PubMed
Search for other papers by Davut Sakiz in
Google Scholar
PubMed
Search for other papers by Murat Calapkulu in
Google Scholar
PubMed
Search for other papers by Sema Hepsen in
Google Scholar
PubMed
Search for other papers by Muhammed Kizilgul in
Google Scholar
PubMed
Search for other papers by Ilknur Unsal Ozturk in
Google Scholar
PubMed
Search for other papers by Bekir Ucan in
Google Scholar
PubMed
Search for other papers by Murat Bayram in
Google Scholar
PubMed
Search for other papers by Busra Betul Cagir in
Google Scholar
PubMed
Search for other papers by Safak Akin in
Google Scholar
PubMed
Search for other papers by Mustafa Ozbek in
Google Scholar
PubMed
Search for other papers by Erman Cakal in
Google Scholar
PubMed
that there may be potential different effects on the thyroid gland. To the best of our knowledge, there is no study in the literature evaluating the effect of exenatide treatment on thyroid gland volume and thyroid-stimulating hormone (TSH). The aim of
Department of Medicine, Thyroid Outpatient Clinic, Division of Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil
Search for other papers by Carolina Castro Porto Silva Janovsky in
Google Scholar
PubMed
Search for other papers by Fernando H. Cesena in
Google Scholar
PubMed
Search for other papers by Viviane Arevalo Tabone Valente in
Google Scholar
PubMed
Search for other papers by Raquel Dilguerian de Oliveira Conceição in
Google Scholar
PubMed
Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil
Search for other papers by Raul D. Santos in
Google Scholar
PubMed
School of Medicine, Faculdade Israelita de Ciências da Saúde Albert Einstein, Sao Paulo, Brazil
Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo School of Medicine, Sao Paulo, Brazil
Search for other papers by Márcio Sommer Bittencourt in
Google Scholar
PubMed
outcome using TSH as continuous and categorical variable Fig. 1. Prevalence of non-alcoholic fatty liver disease, according to thyroid-stimulating hormone quartiles (mUI/L). When further exploring the role of each individual
Institute for Community Medicine, Greifswald, Germany
Search for other papers by Tilman Witte in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Markus M. Lerch in
Google Scholar
PubMed
Search for other papers by Katrin Hegenscheid in
Google Scholar
PubMed
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Medicine, Geisel School of Medicine at Dartmouth, Hanover, N.H., USA
Search for other papers by John A. Batsis in
Google Scholar
PubMed
, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Nakashima M, Nogawa K, Suwazono Y, Nakagawa H: Association between a serum thyroid-stimulating hormone concentration within the normal range and indices of obesity in Japanese men and women. Intern Med
Search for other papers by R. Paschke in
Google Scholar
PubMed
Search for other papers by M. Niedziela in
Google Scholar
PubMed
Search for other papers by B. Vaidya in
Google Scholar
PubMed
Search for other papers by L. Persani in
Google Scholar
PubMed
Search for other papers by B. Rapoport in
Google Scholar
PubMed
Search for other papers by J. Leclere in
Google Scholar
PubMed
a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review. Endocr Pract 2008;14:479–483. 29 Bertalan R, Sallai A, Solyom J, Lotz G, Szabo I, Kovacs B, et al: Hyperthyroidism caused by a germline
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Bengt Hallengren in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
SAT is very rare, and only a limited number of cases of GD occurring after SAT have been reported [ 2 , 3 , 4 , 5 , 6 ]. Here, we report a case of GD with opthalmopathy occurring 11 years after SAT with thyroid-stimulating hormone (TSH) receptor
Search for other papers by Fabián Pitoia in
Google Scholar
PubMed
Search for other papers by Erika Abelleira in
Google Scholar
PubMed
Search for other papers by Graciela Cross in
Google Scholar
PubMed
administration of radioiodine for remnant ablation after recombinant human thyroid-stimulating hormone (rhTSH) therapy achieves results that are good and by no means inferior to the traditional way of preparing patients, i.e. by thyroid hormone withdrawal (THW